oncology Articles
-
Mbd3, a component of the nurd complex, facilitates chromatin alteration and deposition of epigenetic marks
Centre de Regulacio Genomica (CRG), Universitat Pompeu Fabra, Barcelona, Spain; Free University of Brussels, Belgium; San Raffaele Bio-medical Park Foundation, Rome, Italy; European Institute of Oncology, Milan, Italy; ICREA and Centre de Regulacio Genomica (CRG), Barcelona, ...
-
Lehigh Valley Health Network: External Beam Electron Treatment with 3D Printed Modulated and Simple Bolus - Case Study
This patient case demonstrates the clinical application of Adaptiiv’s technology used in radiation oncology through the design and fabrication of both modulated and uniform thickness (simple) ...
-
C-myc target genes involved in cell growth, apoptosis, and metabolism
Departments of Medicine, Molecular Biology and Genetics, and Pathology and The Johns Hopkins Oncology Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland ...
-
Traumatic lumbar punctures in diagnostic and intrathecal treatment punctures of pediatric hemato-oncology patients
Extensive study of CSF laboratory analysis records by pediatricians and Injeq’s researchers has been published as an open access article in Pediatric Hematology and Oncology. Traumatic lumbar punctures in diagnostic and intrathecal treatment punctures of pediatric hemato-oncology patients. 2022 April ...
By Injeq Oy
-
Interview: Teisha Rowland, Ph.D., Principal Scientist, Umoja Biopharma
We had the chance to interview Teisha Rowland, Ph.D., Principal Scientist at Umoja Biopharma during the ISSCR in San Francisco about the Umoja/TreeFrog partnership. Leading iPSC engineering at Umoja, she comes back on the vision of Umoja, its RACR™ technology and her interest in TreeFrog’s C-Stem™ platform for the development of iPSC-derived allogeneic products in ...
-
Defining Oncology and Aging
Cancer survival rates decrease with age, in part because the efficacy of cancer therapies declines in older individuals. Chemotherapy and radiotherapy wreak havoc on the immune system, kill both healthy and cancerous cells alike and cause a buildup of cellular waste in the tissue. This residual waste needs to be either removed from the body or efficiently restored to its original ...
-
Upgrades to Our Cancer Model Database - Case Study
We've added over 125 new datasets to our Cancer Model Database. It provides access to a comprehensive collection of well-established tumor models for early-stage oncology research and increases their translational capabilities to the clinic. The update adds new patient-derived xenograft (PDX) models for several cancer types, including anal, colon, kidney, renal, and leukemia. Additionally, this ...
-
Scripps MD Anderson Cancer Center: SCC of Right Index Fingernail - Case Study
The following patient case demonstrates the application of Adaptiiv’s technology used in clinical radiation oncology through the design and fabrication of customized bolus to improve the efficacy of treating complex target volumes with electron beams. This case is a great example of how a custom modulated electron bolus (MEB) allowed for a uniform dose distribution of a complex treatment ...
-
Mir-21 promotes glioma invasion by targeting mmp regulators
Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Departments of Neurology and Radiology, Massachusetts General Hospital and Neuroscience Program, Harvard Medical School, Boston, Massachusetts, USA; Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, ...
-
Bioimpedance spinal needle provides high success and low complication rate in lumbar punctures of pediatric patients with acute lymphoblastic leukemia
The great results of our latest clinical investigation have now been published as an open access article in Scientific Reports, a respected peer-review journal. Read the article from the journal using the link! Bioimpedance spinal needle provides high success and low complication rate in lumbar punctures of pediatric patients with acute lymphoblastic leukemia. 2022 April 26 Tampere University ...
By Injeq Oy
-
Indication selection for anti-PDx combination therapy In collaboration with big pharma - Case Study
The Challenge: One of the most common challenges in immuno-oncology is identifying the indications and patient populations that would benefit from a specific therapy, especially on top of Standard of Care (SOC) treatments. Our platform tackled this challenge of indication prioritization and patient stratification for a combination of a specific target (A) with an anti-PDX drug that one of our ...
By CytoReason
-
ICT based training on nuclear technology applications in Tanzania
Peaceful application of nuclear technology has contributed to socio-economic resource development in Tanzania. The Tanzania Atomic Energy Commission has taken some active steps for the incorporation and or adoption of ICT-based training modules in nuclear science and technology and its applications. The overall objective of this programme is to establish a sustainable national capability for ...
-
Dr Parag Mallick in conversation with Adam M Hill. `Extra Time` podcast.
Adam talks to Dr Parag Mallick from Stanford University where he is a Professor. Having originally trained as an engineer biochemist, Parag's research is diverse and spans computational and experimental systems biology, cancer biology, and nanotechnology. Parag talks about the diverse applications of proteomics and the value of bringing together different perspectives and disciplines to tackle ...
-
Navigating Cancer’s, Dr. Amila Patel, Provides Insight on Racial Disparities in Recent Cancer Treatment Study
Navigating Cancer, Chief Clinical & Strategy Officer, Dr. Amila Patel, PharmD, BCOP, recently presented data on key findings from a recent abstract with Duke Health revealing racial disparities among head and neck cancer populations at the 2022 American Society of Clinical Oncology conference. Our research, along with our partners at Duke Health, found there were significant health care ...
-
Oncology - Complex Clinical Trials in The Fastest Growing Therapeutic Area
In the developed world, 1 in 4 people die from cancer or cancer-related disease, and cancer accounts for 13% of deaths globally. Oncology is the fastest growing therapeutic area by revenue and number of clinical trials. There’s been a huge emphasis on developing new treatments to improve survival in patients with cancer, but these trials have become a costly undertaking for sponsor ...
-
Overview Of SFA Therapeutics
SFA Therapeutics’ CEO Dr Ira Spector presents an overview of the company and its platform technology SFA Overview Presentation on YouTube Introduction to SFA Liver Disease and Oncology Programs. SFA Oncology More information here We received US Patent 10,143,669B2; to prevent Hepatitis B progression to HCC, a liver cancer that affects 400 million patients and causes 1 million cancer ...
-
Nutrigenomics
Nutrigenomics deals with studying of molecular relationships between nutrition and the response of genes. Also involves the characterisation of gene products and the physiological function and interactions of these products. Nutrigenomics focuses on the effect of nutrients on the genome, proteome, metabolome and explains the relationship between these specific nutrients and nutrient-regimes on ...
-
Navigating Cancer in Collaboration with Experts in Oncology Present Key Research at 2022 ASCO Annual Meeting on Using Digital Health Solutions to Bridge the Health Equity Gap
Navigating Cancer in collaboration with Texas Oncology executes large-scale patient engagement study revealing high digital health solution engagement while demonstrating the opportunity to increase support for diverse patient populations. Scientific and technological advancements have helped enhance cancer care and access to care. Indeed, an important silver lining in the pandemic has been the ...
-
Beyond Just Peptide Antigens: The complex world of peptide-based cancer vaccines
Therapeutic vaccines may well be the next wave of immunotherapy for cancer treatment. Peptide-based vaccines will play a pivotal role in the field. How is a peptide vaccine designed? What other factors such as adjuvants etc should be considered? Can Immunol oncological agents be synergetic with peptide vaccines? Read the full article: Beyond Just Peptide Antigens: The complex world of ...
-
OneThree`s Workflow for Target and Compound Discovery - Case study
Background OneThree Biotech was born out of the largest precision medicine institute in America with the purpose of decreasing the failure rate of bringing therapeutics to market using biology driven artificial intelligence. Our technology was builtin a lab setting; allowing us to engineer our methodologies around real-world results. While working with major biotech and pharma partners; ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you